Is CAFS or MRK a better dividend investment in 2026?

CAFS currently yields 40816.33% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CAFS offers higher current income.

What is the dividend yield difference between CAFS and MRK?

CAFS has a forward dividend yield of 40816.33% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 40813.57 percentage points.

Home › Compare › CAFS vs MRK

CAFS vs MRK: Dividend Comparison 2026

CAFS yields 40816.33% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CAFS wins by $6.335337413603696e+22M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CAFS

● Live price

40816.33%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$6.335337413603696e+22M

Annual income

$63,049,505,730,141,920,000,000,000,000.00

Full CAFS calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CAFS vs MRK

📍 CAFS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CAFS	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CAFS + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CAFS pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAFS

Annual income on $10K today (after 15% tax)

$3,469,387.76/yr

After 10yr DRIP, annual income (after tax)

$53,592,079,870,620,625,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CAFS beats the other by $53,592,079,870,620,625,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAFS + MRK for your $10,000?

CAFS: 50%MRK: 50%

100% MRK50/50100% CAFS

Portfolio after 10yr

$3.167668706801848e+22M

Annual income

$31,524,752,865,070,960,000,000,000,000.00/yr

Blended yield

99.52%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CAFS

No analyst data

Altman Z

-10.5

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAFS buys

MRK buys

No recent congressional trades found for CAFS or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCAFSMRK

Forward yield	40816.33% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$6.335337413603696e+22M	$56.8K ✓
Annual income after 10y	$63,049,505,730,141,920,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$6.333341125941146e+22M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CAFS vs MRK ($10,000, DRIP)

Year	CAFS Portfolio	CAFS Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$4,092,333	$4,081,632.65	$11,206	$366.19	+$4.08M → CAFS
2	$1,565,444,084	$1,561,065,288.22	$12,650	$502.35	+$1565.43M → CAFS
3	$559,764,612,945	$558,089,587,774.68	$14,407	$694.19	+$559764.60M → CAFS
4	$187,102,893,076,834	$186,503,944,940,983.20	$16,585	$967.82	+$187102893.06M → CAFS
5	$58,461,384,295,003,140	$58,261,184,199,410,920.00	$19,342	$1,363.89	+$58461384294.98M → CAFS
6	$17,075,679,818,265,373,000	$17,013,126,137,069,720,000.00	$22,913	$1,947.19	+$17075679818265.35M → CAFS
7	$4,662,453,207,316,437,700,000	$4,644,182,229,910,893,400,000.00	$27,662	$2,823.89	+$4662453207316438.00M → CAFS
8	$1,190,107,817,342,153,000,000,000	$1,185,118,992,410,324,500,000,000.00	$34,159	$4,173.35	+$1190107817342152960.00M → CAFS
9	$283,989,164,387,886,140,000,000,000	$282,715,749,023,330,050,000,000,000.00	$43,337	$6,308.80	+$283989164387886137344.00M → CAFS
10	$63,353,374,136,036,960,000,000,000,000	$63,049,505,730,141,920,000,000,000,000.00	$56,776	$9,798.13	+$6.335337413603696e+22M → CAFS

CAFS vs MRK: Complete Analysis 2026

CAFS — Stock

Café Serendipity Holdings, Inc., a development stage company, focuses on building upscale turnkey franchises to the recreational and medical marijuana industry in the United States. It intends to market a product line of accessories, apparel, coffee and teas, bakery and other edibles, lotions, marijuana, and oils through a coast to coast franchise and dealer network to the recreational and the approximately 6,000 existing legal medical marijuana dispensaries. The company is based in Newport Beach, California.

Full CAFS Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CAFS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAFS vs SCHD CAFS vs JEPI CAFS vs O CAFS vs KO CAFS vs MAIN CAFS vs JNJ CAFS vs ABBV CAFS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.